Selenium Nanoparticles Coated with Bacterial Polysaccharide as Anti-Lung Cancer Agents
Author Information
Author(s): Shehata Nourhan S., Elwakil Bassma H., Elshewemi Salma S., Ghareeb Doaa A., Olama Zakia A.
Primary Institution: Pharos University in Alexandria, Alexandria, Egypt
Hypothesis
The study aims to enhance the production of bacterial exopolysaccharides as a coating agent for selenium nanoparticles to improve their biological activity against lung cancer.
Conclusion
The synthesized bacterial exopolysaccharide-coated selenium nanoparticles are effective as multi-functional antimicrobial, anticancer, and antioxidant agents.
Supporting Evidence
- The synthesized selenium nanoparticles showed a potent cytotoxic effect against A549 cells.
- AZEPS-SeNPs demonstrated a significant antifungal effect against Candida albicans.
- The study utilized Taguchi's approach for optimizing exopolysaccharide production.
- AZEPS-SeNPs exhibited a therapeutic index indicating their safety.
- The in vivo study showed improved histopathological examination of lung tissue sections.
- AZEPS-SeNPs increased reactive oxygen species production in cancer cells.
- The study concluded the efficiency of the synthesized bacterial EPS-SeNPs as multi-functional agents.
Takeaway
Scientists made tiny particles from selenium and a natural substance from bacteria to help fight lung cancer and kill germs.
Methodology
The study involved in vitro tests on human lung adenocarcinoma cells and in vivo tests on mice, using synthesized selenium nanoparticles coated with bacterial exopolysaccharides.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully represent human responses.
Participant Demographics
The in vivo study used forty albino male mice aged three months.
Statistical Information
P-Value
1.724 ± 0.08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website